Mass Balance of Oral [14C]TPN171H in Healthy Male Subjects

Phase 1 Completed 6 enrolled Vigonvita Life Sciences Shanghai Institute of Materia Medica, Chinese Academy of Sciences · collab

NaSingle-groupOpen-labelBasic science

Summary

This study is objective to evaluate the in vivo absorption, excretion and biotransformation pathways of \[14C\]-TPN171H in Chinese male healthy volunteers, and to reveal the overall pharmacokinetic characteristics of TPN171H in human body, so as to provide basis for rational use of the drug.

Timeline

Start: 2020-11-26
Primary completion: 2021-01-27
Completion: 2021-01-27

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	TPN171H	Unknown	10 mg	Oral

Indications

No indication recorded.